Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Patients With Rheumatoid Arthritis Continue to Benefit After Halting TNF-alpha Inhibitor Therapy
Link ID 838
Title Patients With Rheumatoid Arthritis Continue to Benefit After Halting TNF-alpha Inhibitor Therapy
Url http://www.medscape.com/viewarticle/565701?src=rss
Description The improvement gained through tumor necrosis factor-alpha inhibitor therapy persists after withdrawal of treatment. Medscape Medical News
Category Articles > Rheumatology
Keywords
Date Nov 15, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. ACR 2007 Update on Treatment Advances for Systemic Lupus Erythematosus
  Doruk Erkan, MD, presents the latest from ACR 2007 on the current and emerging treatments for systemic lupus erythematosus.
Medscape Rheumatology
Category:   Articles > Rheumatology


2. Synovial Biopsy in the Evaluation of Nonrheumatic Systemic Diseases Causing Arthritis
  A variety of systemic diseases not generally considered as rheumatic diseases can involve joints and can create differential diagnostic dilemmas. These diseases are reviewed in this article.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


3. B-Cell-Targeted Therapies: Reports From the ACR 2007 Annual Meeting
  Review recent data supporting safety and efficacy of B-cell-depleting agents for RA, as illustrated by data presented at American College of Rheumatology 2007 Annual Meeting.
Medscape Rheumatology
Category:   Articles > Rheumatology


4. Rituximab Plus Cyclophosphamide Useful Against Refractory SLE
  Treatment with rituximab along with cyclophosphamide can be helpful in patients with severe and refractory systemic lupus erythematosus (SLE), Swedish researchers report in the March issue of Annals of the Rheumatic Diseases. Reuters Health Information
Category:   Articles > Rheumatology


5. Belimumab May Be Effective Treatment for SLE
  A new combined endpoint for a phase 2 trial demonstrates that belimumab improves systemic lupus erythematosus disease activity. Medscape Medical News
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS